Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "Epinephrine Autoinjectors - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Epinephrine Autoinjectors was estimated at US$2.5 Billion in 2023 and is projected to reach US$3.6 Billion by 2030, growing at a CAGR of 4.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. 
Key insights into the Global Epinephrine Autoinjectors Market highlight the significant growth of the 0.15 gm Dosage Epinephrine Autoinjectors segment, which is projected to reach US$2.5 billion by 2030, growing at a 4.6% CAGR. The 0.30 gm Dosage Epinephrine Autoinjectors segment is also forecasted to expand at a 5.6% CAGR over the next eight years.
Regional analysis shows the U.S. market, valued at $756.1 million in 2023, and China, expected to grow at a 4.5% CAGR to reach $634.5 million by 2030. Other key regions for growth include Japan, Canada, Germany, and the Asia-Pacific.
This report offers comprehensive market data, with independent analysis of annual sales and forecasts in US$ million from 2023 to 2030. In-depth regional analysis includes insights across the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Company profiles cover key players like ALK-Abello A/S, Bausch + Lomb UK Ltd- Emerade, and Teva Pharmaceutical Industries Ltd. The report also offers complimentary updates for a year to keep readers informed of market developments.
Key Questions Answered:
- How is the Global Epinephrine Autoinjectors Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 193 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $2.5 Billion |
| Forecasted Market Value (USD) by 2030 | $3.6 Billion |
| Compound Annual Growth Rate | 4.8% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of COVID-19 and a Looming Global Recession
- Epinephrine Autoinjectors - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
FOCUS ON SELECT PLAYERS (Total 44 Featured)
- ALK-Abello A/S
- Bausch + Lomb UK Ltd- Emerade
- Teva Pharmaceutical Industries Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/uonxbs
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
